This approval was based on detailed comparisons of immunogenicity, safety, and efficacy between autologous and allogeneic stem cells, 14,15 and also considered stem cells derived from different sources
Lyall V, Alam RI, Phan DQ, Ereso GL, Phan TH, Malik SA, Montrose MH, Chu S, Heck GL, Feldman GM, DeSimone JA
10.1053/j.gastro.2013.04.056 17
One of the innovative approaches we offer involves GLP-1-based therapies
Fatigue typically resolves by the end of the first month on a given dose and then returns briefly with each dose escalation as the body adjusts